| Date | Title | Description |
| 16.07.2026 | DeweyLearn Raises $5M in Series A Funding | DeweyLearn, a NYC-based provider of a multimodal AI platform that understands human learning at scale, raised $5M in Series A funding.
The round was led by SJF Ventures with participation from Catalysis Capital, Morningside, and Owl Venture... |
| 16.07.2026 | DeweyLearn Raises $5 Million Series A To Scale AI-Powered Skills Assessment | DeweyLearn has raised $5 million in an oversubscribed Series A funding round to expand its multimodal artificial intelligence platform for evaluating real-world skills and delivering expert-level feedback at scale. SJF Ventures led the roun... |
| 16.07.2026 | AdvanCell Closes $315 Million Series D |
BOSTON, MA, AdvanCell, a clinical-stage radiopharmaceutical company, announced the closing of an oversubscribed and upsized $315 million Series D financing.
>> Click here for more funding data on AdvanCell
>> To export AdvanCel... |
| 15.07.2026 | AdvanCell Closes US $315M in Series D Funding | AdvanCell, a Boston, MA- and Brisbane, Australia-based clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, raised US $315M Series D in funding.
The round was led by Ally Bridge Group and Alpha Wave, al... |
| 15.07.2026 | AdvanCell Closes $315 Million Series D Financing To Advance Targeted Alpha Therapies | AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, announced the closing of an oversubscribed and upsized $315 million Series D financing. The round was led by Ally Bridge Group and co-le... |
| 14.07.2026 | Mighty Therapeutics Secures Up To $150 Million To Advance Mitochondrial Targeted Medicines | Mighty Therapeutics announced the closing of transactions securing up to $150 million in non-dilutive growth and equity capital. The financing is designed to support the company’s commercial and clinical development plans for a new class of... |
| 14.05.2026 | Ampa: Oversubscribed Financing Accelerates Rollout Of Portable Depression Treatment Platform | Ampa announced an oversubscribed financing round to accelerate the rollout of its FDA-cleared Ampa One transcranial magnetic stimulation (TMS) system, which is already in use by clinics across more than 30 U.S. states. The company also anno... |
| 14.05.2026 | Ampa Raises Financing; Total Reaches Over $25M | Ampa, a Palo Alto, California-based developer of a portable transcranial magnetic stimulation (TMS) platform for depression, raised a financing of undisclosed amount.
The round was led by a syndicate including Morningside Ventures, Trimera ... |
| 07.04.2026 | SimpliFed Secures $10.8M to Expand Virtual Maternal Health Platform | What You Should Know:
The Funding: SimpliFed, a virtual maternal healthcare platform, has raised $10.8 million in an oversubscribed Series A round led by Morningside and Hesperia Capital.
The Strategic Evolution: Originally founded as a vir... |
| 07.04.2026 | SimpliFed Raises Over $10 in Series A Funding | SimpliFed, a NYC-based maternal healthcare company providing virtual breastfeeding and baby feeding support for new parents, raised over $10M in Series A funding.
The round was led by Morningside and Hesperia Capital with participation from... |
| 22.10.2025 | Ampa Raises $8.5M in Pre-A Funding | A clinician administering treatment with the Ampa One system – a portable, cameraguided TMS device designed to make advanced brain stimulation more accessible and easy to deliver.
Ampa, a Palo Alto, CA-based neurotechnology company, raised ... |
| 18.10.2025 | Brook.ai Secures $28M for AI-Driven Remote Healthcare Expansion | Brook.ai landed $28 million in Series B funding. This investment propels national remote patient care expansion. The platform merges AI with clinical expertise. It delivers continuous, "always-on" support for patients. Proven resu... |
| 17.10.2025 | Brook.ai: $28 Million Series B Closed For Advancing Remote Care Platform | Brook.ai, an innovator in remote patient care, has secured $28 million in Series B financing to accelerate its national expansion and further advance its outcomes-driven model for continuous healthcare delivery. The funding round was co-led... |
| 16.10.2025 | Brook.ai Raises $28M to Scale Remote Care Model Nationwide | What You Should Know:
– Brook.ai is making remote care an integral part of U.S. healthcare, extending continuity of care outside the traditional practice setting and delivering measurable improvements in patient outcomes.
– The company’s su... |
| 02.09.2025 | EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion | EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion
Tue, Sep 02, 2025 11:00 CET Report this content
Amsterdam, The Netherlands, September 2, 2025 – EQT Life Sciences is pleased to announce th... |
| 01.09.2025 | Cambrige’s Cyted Health raises over €37 million to improve early detection and prevention of oesophageal cancer | Cyted Health, a British gastrointestinal (GI) molecular diagnostics company, announced this weekend a first close of €37.5 million in its Series B financing round to accelerate its ongoing US expansion.
The round was led by EQT Life Science... |
| 17.06.2025 | HOPPR Secures $31.5M Series A to Scale AI Infrastructure for Medical Imaging | Backed by top-tier investors, HOPPR is scaling its secure platform for enabling developersand medical imaging partners to build, refine, and deploy AI applications.
HOPPR, the company revolutionizing how AI imaging applications are built, v... |
| 26.03.2025 | Capitala Group and Xealth: A Tale of Two Investments in Growth | In the bustling world of finance and technology, two stories emerged recently, each a testament to the power of investment in driving growth. Capitala Group, a private markets investment firm, and Xealth, a digital health company, both secu... |
| 26.03.2025 | Fleetio's Bold Move: A $450 Million Leap into Fleet Maintenance Innovation | In the fast-paced world of fleet management, change is the only constant. Fleetio, a Birmingham-based software powerhouse, has just made waves with a monumental $450 million Series D funding round. This isn’t just a cash infusion; it’s a st... |
| 25.03.2025 | Xealth Receives Investment from Morningside Ventures | Xealth, a Seattle, WA-based company that develops digital health enablement solutions for health systems, received an investment from Morningside Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to ex... |
| 25.03.2025 | Fleetio Raises over $450M in Series D; Acquires Auto Integrate | Fleetio, a Birmingham, AL-based provider of a fleet optimization software platform, raised over $450M in Series D funding.
The round was led by Elephant and new investor Growth Equity at Goldman Sachs Alternatives.
The company has also acqu... |
| 19.02.2025 | SimpliFed: $4 Million Raised For Building Maternal Care At Home Platform | Virtual maternal healthcare SimpliFed announced that it has raised a new $4 million in funding. This funding was led by Morningside and included new investors The Artemis Fund, Cultivation Capital, and American Heart Association Social Impa... |
| 07.02.2025 | SimpliFed: A New Dawn in Virtual Maternal Healthcare | In the realm of maternal healthcare, a revolution is brewing. SimpliFed, a New York City-based company, has secured $4 million in funding to expand its virtual maternal healthcare platform. This investment, led by Morningside and supported ... |
| 04.02.2025 | SimpliFed Raises $4M to Expand Virtual Maternal Healthcare Platform | What You Should Know:
– SimpliFed, a provider of virtual maternal healthcare, today announced a $4M funding round led by Morningside.
– The investment will support the company’s expansion from a point solution focused on baby feeding to a c... |
| 10.01.2025 | Geneoscopy: $105 Million (Series C) Raised For Developing Advanced Gastrointestinal Diagnostic Tests | Geneoscopy – a life sciences company focused on developing diagnostic tests for advancing gastrointestinal health – announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joine... |
| 09.01.2025 | Geneoscopy's Bold Leap: $105M Series C Funding Fuels Gastrointestinal Diagnostics Revolution | In the world of healthcare, innovation is the lifeblood. Geneoscopy, a St. Louis-based life sciences company, has just injected a hefty $105 million into its veins through a Series C funding round. This financial boost is not just a number;... |
| 08.01.2025 | Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests | Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease
ST. LOUIS & HERCULES, Calif. – Jan. 8, 2025 — Geneoscopy, I... |
| 08.01.2025 | Geneoscopy Closes $105M in Series C Funding | Geneoscopy, a St. Louis, MO-based life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, raised $105M in Series C funding.
The round was led by Bio-Rad Laboratories (NYSE: BIO and BIO.B)... |
| 20.11.2024 | Alentis Therapeutics: $181.4 Million (Series D) Raised For Advancing Clinical Development Of Anti-Claudin-1 ADCs | Alentis Therapeutics – a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis – announced that it has raised $181.4 million in Series D financing, supported by a syndicate of t... |
| 13.11.2024 | Alentis Therapeutics Secures $181.4 Million to Pioneer Cancer Treatments | In a bold move to reshape cancer treatment, Alentis Therapeutics has successfully raised $181.4 million in an oversubscribed Series D funding round. This infusion of capital, led by OrbiMed and co-led by Novo Holdings and Jeito Capital, sig... |
| 13.11.2024 | Alentis Therapeutics: $181.4 Million (Series D) Raised To Develop Treatments For Claudin-1 Tumors | Alentis Therapeutics – a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis – announced that it has raised $181.4 million in Series D funding, supported by a syndicate of top... |
| 12.11.2024 | Alentis Therapeutics raises $181.4 million in oversubscribed series D round | Normal 0 false false false EN-GB X-NONE AR-SA
Besides OrbiMed, Novo Holdings and Jeito Capital, Alentis Therapeutics’ series D round saw the participation of new investors Frazier Life Sciences, Longitude Capital, Catalio Capital, Piper Hea... |
| 19.09.2024 | Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer | NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative dise... |
| 11.09.2024 | PhoreMost raises £33M to advance 'Drugging the Undruggable' research | PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round.
PhoreMost’s SITESEEKER platform can identify the best new the... |
| 20.08.2024 | Koa Health Launches Proactive Mental Health Solution For Employers to Unify and Simplify the Continuum of Care | The clinically validated, unified platform aims to move beyond just therapy to deliver easy-to-use, real-time prevention, treatment, and maintenance for employees who may be suffering from anxiety, depression, sleeplessness, burnout, or oth... |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 13.03.2024 | Heart Planet Co., Ltd. Launch in Japan Smartwatch specialty brand “Mibro” is finally officially released in Japan! | [Heart Planet Co., Ltd.] [Launch in Japan] Smartwatch specialty brand “Mibro” is finally officially released in Japan!
*View in browser* *Heart Planet Co., Ltd.*
Press release: March 13, 2024
**
[Launch in Japan] Smartwatch specialty brand ... |
| 12.03.2024 | Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease | -Following positive pre-submission meetings with regulators, Prilenia plans to submit its MAA for pridopidine in Huntington’s disease (HD) in mid-2024-
-If approved, pridopidine could be commercially available to patients in Europe as early... |
| 12.03.2024 | Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease | NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)-- Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative disease... |
| 01.11.2023 | AdaptX Secures $10M for AI-Powered, Self-Serve Clinical Management | What You Should Know:
– AdaptX, a self-serve clinical management solution company raises $10M in funding led by Cercano Management and included participation from notable entities, such as Memorial Hermann Health System, Morningside Venture... |
| 01.09.2022 | With schools increasingly focused on mental health, PsycApps raises seed round for US expansion | I’ve been tracking PsycApps, a startup that came up with a gamified mental health game called eQuoo, since 2016, and this company — and its founder — is nothing if not persistent in “pivoting into the wind”. The last we heard it had been ap... |
| 01.09.2022 | Gamified mental health app PsycApps plays in €1.7 million | UK-based health tech startup PsycApps has raised €1.7 million in funding from US-based Morningside Ventures to develop its evidence-based gaming app, eQuoo. The extra cash will enable the startup to boost its mental health platform.
About 5... |
| 24.07.2022 | Triastek and Eli Lilly partner to 3D print gastrointestinal drugs | Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals company Eli Lilly to research and develop 3D printed oral drugs for the gastrointestinal tract.
Specifically, the project will leverage Triastek’... |
| 11.05.2022 | SimpliFed Raises $6M for Virtual Breastfeeding & Baby Feeding Support | What You Should Know:
– SimpliFed, the telehealth platform dedicated to democratizing access to baby feeding services, announced it has closed $6M in its seed round, led by Morningside Ventures and The Venture Collective, with participation... |
| 17.03.2022 | MIT Receives $100 Million Gift To Form New Multidisciplinary Design Center | The Massachusetts Institute of Technology (MIT) has received a $100 million gift from the ... [+] Morningside Foundation, which will be used to create a new center for design. getty |
| 21.01.2022 | Casana Raises $30M for Effortless Home Health Monitoring | What You Should Know:
– Casana, a healthcare technology firm that is reinventing in-home health monitoring announced it has raised $30M in Series B funding, bringing the total capital raised to $46 million led by Morningside with participat... |
| 23.11.2021 | IP : Ieso Digital Health Ltd - ieso raises $53m to address global mental health crisis with digital therapeutics | UK innovator closes Series B financing to develop AI-enabled, evidence-based digital therapeutics built on the world's largest mental health treatment data set
ieso has completed its £39million ($53 million) Series B financing round led by... |
| 11.11.2021 | The Week in Agrifoodtech: Fazenda Futuro nets $58m; Growers Edge buys FarmlandFinder assets | There was plenty of newsworthy M&A action over the past week.
US food delivery company DoorDash announced a deal to acquire Finnish counterpart Wolt in an $8.1 billion all-stock transaction; while US cloud kitchen company Reef took over... |
| 05.11.2021 | EXCLUSIVE: Biopesticide startup Robigo raises pre-seed funding to make ‘molecular vigilantes’ | US-based Robigo has raised $1.15 million in pre-seed funding for its biopesticide technology platform. Morningside Group, First Star Ventures, and an unnamed angel participated in the round.
Co-founder Connor Sweeney tells AFN that the new ... |
| 03.11.2021 | Wellinks Secures $25M to Expand Virtual COPD Management Solution | What You Should Know:
Wellinks, a digital health company for virtual COPD, announced it has closed a $25M funding round, led by new investor Morningside Venture Investments and joined by returning investors HighCape Capital, Connecticut Inn... |
| 03.10.2021 | 🦄 Another week, another unicorn | Good morning everyone! Do you know what day it is? It’s New Ventures BC (NVBC) Competition Awards Ceremony Eve. That’s right, tomorrow night we find out who will take the top spot in the 21st edition of the annual competition. It started wi... |
| 29.09.2021 | Semios raises $100m to scale precision ag platform with more acquisitions likely | Semios, the Vancouver, Canada-headquartered precision ag platform, has closed $100 million in late-stage funding.
The round was led by Morningside Group, a Boston-based private equity and venture capital firm. It brings the company’s total ... |
| 29.09.2021 | “It’s now ours to lose and we don’t intend on losing.” — Semios, now $100M richer, has gone from greenhouse to powerhouse to unicorn | Vancouver agtech juggernaut Semios has raised $100 million in funding led by Morningside Group, a Boston-based private equity and venture capital firm focused on investing in socially responsible businesses. This funding takes Semios into B... |
| 10.08.2021 | Brief: GreenLight Biosciences agrees to go public in $1.2bn SPAC merger | GreenLight Biosciences, an ag biotech company using the RNA technology made famous by Covid-19 vaccines, has agreed to merge with a special purpose acquisition company (SPAC) in a deal that will value the company at $1.2 billion and list it... |
| 30.07.2021 | Стартапы Японии и Китая: самые успешные стартапы 2021 года | Стартапы Японии и Китая: самые успешные стартапы 2021 года |
| 06.07.2021 | Linus Health raises $55M for early screening for Alzheimer’s disease | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Linus Health, a digital health company focused on... |
| 06.07.2021 | Linus Health raises $55M for early screening for Alzheimer’s disease | Did you miss a session from the Future of Work Summit? Head over to our Future of Work Summit on-demand library to stream.
Linus Health, a digital health company focused on improving brain health, has raised $55 million in funding for scree... |
| 16.06.2021 | USD67 million for Alentis Therapeutics | |
| 16.06.2021 | USD67 million for Alentis Therapeutics | Alongside Morningside Venture Investments, Jeito Capital and Series A investors BioMed Partners, BB Pureos Bioventures, Bpifrance through its InnoBio 2 fund, High-Tech Gründerfonds and Schroders Capital joined Alentis’ financing round.
&quo... |
| 18.05.2021 | Hummingbird Bioscience : Raises US$125 Million in Series C Financing | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the... |
| 18.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Financing | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the... |
| 17.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Financing | |
| 03.12.2020 | Everlywell Secures $175M to Expand Position in At-Home Testing Market | What You Should Know:
– Everlywell secures $175M in Series D funding to expand its virtual care offerings, scale its testing and infrastructure, drive clinical research and disease management through testing, and grow its national leadershi... |
| 23.09.2020 | SBC occupier Immune Regulation Limited raises £40.6 million Series B equity financing | SBC occupier Immune Regulation Limited raises £40.6 million Series B equity financing
23-09-2020
Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies.... |
| 23.09.2020 | SBC occupier Immune Regulation Limited raises £40.6 million Series B equity financing | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies.
London UK and Boston USA... Immune Regulation Limited, a US and UK based clinical stage biotechn... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 million Series B Equity Financing | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies
(London UK and Boston USA, 21 September 2020) Immune Regulation Limited (“Immune Regulation”), a... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 million Series B Equity Financing | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies
(London UK and Boston USA, 21 September 2020) Immune Regulation Limited (“Immune Regulation”), a... |
| 17.06.2020 | How the Colorado potato beetle inspired a $102 million fundraise – and could yet inspire a Covid-19 vaccine | UPDATE: Wednesday June 17, 4:55pm ET to add comments from GreenLight investor S2G.
Switching sharply to developing a vaccine for Covid-19 appears to have proved a boon for GreenLight Biosciences, a company that previously focused on develop... |
| 16.06.2020 | GreenLight Supercharges Efforts with $102M in Funding | BOSTON, June 16, 2020 – GreenLight Biosciences today announced it has raised an oversubscribed $102 million round of funding from new and existing investors to rapidly expand production of its RNA products for agricultural and life sciences... |
| 19.09.2018 | EXCLUSIVE: Milk & Eggs Raises $6m Seed Funding for ‘Made-to-Order’ Online Farmers Market | Milk & Eggs, a Los Angeles-based online perishable food market and delivery service connecting farmers and artisanal food makers with consumers, has completed a $6 million seed round.
Morningside Venture Capital, an early-stage venture ... |
| 28.06.2018 | India’s Cashify raises $12M for its second-hand smartphone business | Cashify, a company that buys and sells used smartphones, is the latest India startup to raise capital from Chinese investors after it announced a $12 million Series C round.
Chinese funds CDH Investments and Morningside led the round, which... |
| 15.01.2018 | Pony.ai raises $112 million Series A for autonomous cars | Baidu and Google self-driving alum team up to transform transportation
We've solved for our ability to work remotely - thanks to computers and smartphones. Now we're solving for our ability to shorten our commute from home to work -- thanks... |
| 08.06.2017 | Brief: Freight Farms Raises $7.3m Series B Round For Shipping Container Tech | Freight Farms, the startup growing lettuce inside shipping containers, has completed its Series B funding round on $7.3 million.
AgFunderNews first reported the round in April when an SEC filing revealed the company had closed $5.7 million ... |
| 13.04.2017 | Agtech Funding Sheet: SEC Filing Reveals Freight Farms Has Raised $5.7m Towards Larger Series B | Freight Farms, the startup growing lettuce inside shipping containers, has raised $5.7 million in an $8 million round, according to a SEC filing. Since the startup raised $3.7 million in Series A funding in 2014, this could be its Series B ... |
| 31.03.2017 | China: Morningside closes first RMB fund at $140m backed by Tencent, Xiaomi, others | Premium
China’s Morningside Venture Capital (Morningside), an early-stage venture capital (VC) firm has closed its maiden RMB-denominated fund at $140 million hard cap, according to a report in China Money Network.
Continue reading this sto... |
| 28.03.2017 | Health IT startup raises $11M+ to screen children for behavioral disorders, including autism | “Parents typically see signs at 18 months, but the average age for a diagnosis is 4 years old,” Vaughan said in his pitch. “For attention deficit hyperactivity disorder, it’s 7 years old.”
Morningside, a private equity and venture capital f... |
| 28.03.2017 | Cognoa Raises $11.6M in Funding | Cognoa, a Palo Alto, CA-based digital health company, raised $11.6m in funding.
The funding was provided by existing investor Morningside.
The company, which has raised more than $20m since founding, will use the capital to advance its mach... |
| 02.11.2016 | Harvard Square Real Estate Mogul Backs an Edtech Startup | CollegeVine, a Cambridge-based startup providing mentoring services for college applicants, announced Wednesday it closed $3.1 million in Series A funding. The round was led by Morningside Technology Ventures, which was co-founded by Gerald... |
| 17.05.2016 | China’s workout app KEEP $32m Series C from Morningside Ventures, GGV Capital | Premium
Chinese workout mobile app KEEP has snapped up a $32 million series C funding round led by Hong Kong-based private equity and venture capital firm Morningside Ventures and multi-stage VC investor GGV Capital, according to a China Mo... |
| 01.02.2016 | Daily funding roundup - February 1, 2016 | Creandum landed $197M; Federated Wireless raised $22M; Atom Tickets $50M funding
4G Clinical, a Boston, MA-based randomization and trial supply management company, secured $2.5 million in Series A funding. The round was led by Boston-based ... |
| 26.01.2016 | Daily funding roundup - January 26, 2016 | Grovo announced $40 funding; Vidyard nabbed $35M; Cedexis closed $22M Series B funding
Grovo, a SaaS-based learning management system (LMS) for companies, today announced that it has closed $40 million in a Series C funding round led by exi... |
| 18.11.2015 | Daily funding roundup - November 18, 2015 | Ola bagged $500M; Joyable raised $8M; Test IO landed $5M
TestCloud, a self-service crowdtesting platform for app and Web developers, has a new name and a big new round of funding, the company announced on Wednesday, all to facilitate a big ... |
| 16.09.2015 | Daily funding roundup - September 16, 2015 | Sunlight Financial bagged $300M; Lightspeed secured $61M; Omada Health raised $48M
We don't talk about it much in this country for some reason, but diabetes and heart disease are huge problems. So big that three out of four Americans now ha... |
| 09.06.2015 | Luqa Pharmaceuticals Completes US$15M Funding | Luqa Pharmaceuticals, a China-based specialty care company that markets innovative solutions in dermatology and other specialty areas, completed a US$15m round of funding.
The round was led by Morningside Ventures.
The company intends to us... |
| 28.04.2015 | InCarda Therapeutics Raises over $5M in Series A Financing | InCarda Therapeutics, Inc., a San Francisco, CA-based biotechnology company focused on the development and commercialization of therapies for acute cardiovascular conditions via the inhalation route, raised over $5m Series A financing.
Pote... |
| 10.11.2014 | iCarsClub gets $60m Series B funds for China arm | Premium
Singapore’s iCarsClub has raised $60 million, in Series B round of funding, for its China venture – PPzuche, a Chinese peer-to-peer (P2P) car-rental – from IDG Capital Partners & MorningSide Ventures.
Continue reading this story... |
| 22.10.2014 | InSilixa Raises $13M Financing | InSilixa, a Sunnyvale, California-based molecular diagnostic (MDx) platform developer, raised a $13M financing round.
The round was led by PointGuard Ventures and Morningside. In conjunction with the funding, Pete Thomas, Managing Director,... |
| 14.10.2014 | DNAtrix Completes $20M Series B Round |
SAN DIEGO, CA, Clinical-stage oncolytic immunotherapy company, announced that it has completed a $20M Series B equity financing.
>> Click here for more funding data on DNAtrix
>> To export DNAtrix funding data to PDF and Exc... |
| 14.10.2014 | DNAtrix Completes $20M Series B Equity Financing | DNAtrix, a Houston, Texas and San Diego, California-based clinical-stage oncolytic immunotherapy company, completed a $20M Series B equity financing.
The round was led by new investor Morningside Ventures with participation from existing in... |
| 08.09.2014 | A big moment for public health as Harvard’s school takes in $350M gift | In the announcement, Harvard’s president, Drew Gilpin Faust, noted that the world’s slow response to the Ebola outbreak underscores how public health has been under-resourced. “We’re all realizing how important public health is as we become... |
| 02.07.2014 | Synchroneuron Closes $20M Series B Funding | Synchroneuron, a Waltham, MA-based biopharmaceutical company focused on developing new therapies to treat tardive dyskinesia (TD) and other neuropsychiatric disorders, closed a $20m Series B funding.
The round came from sole-investor Mornin... |
| 21.10.2013 | Kona Medical Completes $10M Series D Financing | Kona Medical, a Bellevue, Wash., and Menlo Park, Calif.-based developer of treatments for hypertension, completed a $10m Series D financing round.
Morningside Group was the sole investor.
The company intends to use the funds for the China m... |
| 22.08.2013 | MicuRx Pharmaceuticals Raises $25M in Series B Financing | MicuRx Pharmaceuticals, Inc., a Hayward, CA-based biopharmaceutical company developing innovative antibiotics, raised $25m in Series B financing.
The round was led by BVCF, with participation from existing investors Morningside Group and De... |
| 01.11.2012 | Advanced Cell Diagnostics Raises $12M in Series B Financing | Advanced Cell Diagnostics Inc. (ACD), a Hayward, CA-based life science research and clinical diagnostics company, has raised $12m in Series B financing.
Backers include New Leaf Venture Partners and Morningside Ventures.
The company intends... |
| 25.10.2012 | MicuRx and Shanghai Zhangjiang Biomedical Industry Venture Capital Partner to Develop Next-generation Antibiotic MRX-I for Chinese Market | -- Joint Venture Shanghai MengKe Pharmaceuticals, Inc. Established--
HAYWARD, Calif. and SHANGHAI, Oct. 24, 2012 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics... |
| 06.02.2012 | Synchroneuron Closes $6M Series A Financing with Morningside Technology Ventures | Synchroneuron Inc., a Waltham, Mass.-based biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders, has closed a $6m Series A financing with Morningside Technology Ventures Ltd.... |
| 17.11.2011 | Oxyrane Raises $26.5M in Series D Funding | Oxyrane UK Limited, a Manchester, England, UK-based biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, has raised $26.5m in Series D funding round.
Backers inclu... |
| 20.04.2011 | Aduro BioTech Completes $19.25M Series B Equity Financing | Aduro BioTech, a Berkeley, CA-based clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases, has completed a $19.25m Series B equity financing.
Investors i... |
| 22.01.2011 | Clean Membranes Closes Series A Financing Round | Clean Membranes, Inc, a Lexington, MA-based start-up developing a new generation of non-fouling membranes, has closed its Series A round of financing.
The investment, whose amount remained undisclosed, was led entirely by Morningside Ventur... |
| 18.10.2009 | Plastic Logic unveils Que eBook reader for business people | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Taking on the Amazon Kindle eBook reader, Plastic... |
